-
EEG from bench to bedside: Conventional electrophysiological biomarkers and applied deep learning in Psychiatry
Sebastian Olbrich
-
To be announced
John J. Foxe, PhD
-
Mechanisms Behind Neurotechnology-Assisted Rehabilitation: First Results from a Double-Blind Randomized Controlled Trial
Reinhold Scherer, PhD
-
Performance monitoring, post-error adjustments, and acetylcholine
Prof. Dr. med. habil. Markus Ullsperger
-
The pull of environmental affordances on selective attention
Dr. Zakaria Djebbara
-
Repetitive transcranial magnetic stimulation improves postoperative functional recovery in glioma patients: insights from Beijing Tiantan Hospital
Dr. Fan Xing on behalf of Prof. Jiang Tao
-
Has the time come to update the standard TMS machine?
Prof. John Rothwell
-
To be announced
Prof. Giorgio di Lorenzo
-
To be announced.
Michael Funke, MD PhD
-
Non-Invasive Remote EEG Monitoring at Home in Epilepsy: Insights from the EEG@HOME Study
Dr. Andrea Biondi
Chris Baeken, MD, PhD, is a consultant psychiatrist and full-time Associate Professor of Psychiatry at Ghent University, Belgium. He also holds a part-time associate professorship at the Vrije Universiteit Brussel (VUB), and is senior research fellow at the Technical University Eindhoven, the Netherlands. As Principal Investigator of the Ghent Laboratory for Experimental Psychiatry (GHEP) and member of the Centre for Neurosciences at VUB, his research focuses on the neurobiological mechanisms of emotion processing in both healthy and mentally ill populations. Dr Baeken specialises in multimodal neuroimaging (MRI, fMRI, PET) and neurostimulation techniques (rTMS, tDCS) to better understand neuropsychiatric disorders such as depression, schizophrenia and dementia. His recent work explores innovative stimulation parameters and accelerated rTMS protocols, extending his research into both human and canine models.
Repetitive transcranial magnetic stimulation (rTMS) has been used to treat major depressive disorder for more than two decades. More recently, accelerated rTMS protocols have been developed to increase response rates by delivering the same number of sessions in a significantly shorter time frame compared to traditional protocols that span two to four weeks. While this accelerated approach has shown promise in achieving faster clinical responses and reducing overall treatment duration, the underlying neurobiological mechanisms responsible for these mood changes remain poorly understood. This presentation will provide an overview of the latest findings on these mechanisms.